Search clinical trials for: Adenocarcinoma of the Pancreas
Total 448755 results
-
Corcept TherapeuticsTerminatedMetastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Sumitomo Pharma America, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
Sumitomo Pharma America, Inc.CompletedCarcinoma, Pancreatic DuctalUnited States, France, Netherlands, Spain, Taiwan, China, Belgium, Korea, Republic of, Austria, Singapore, Japan, Italy, Germany, Portugal, Poland, Czechia, Australia, Canada, Russian Federation, Ukraine
-
Mohammed Najeeb Al HallakNational Cancer Institute (NCI)CompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage IV Pancreatic CancerUnited States
-
MacroGenicsTerminatedPancreatic CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...The Skip Viragh FoundationActive, not recruiting
-
National Institutes of Health Clinical Center (CC)CompletedAdenocarcinoma of the Pancreas | Stage III Pancreatic Cancer | Stage IVA Pancreatic CancerUnited States
-
Aravive, Inc.TerminatedPancreatic AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); The Skip Viragh FoundationCompleted
-
Anwaar SaeedActuate Therapeutics Inc.; Incyte CorporationActive, not recruitingPancreatic AdenocarcinomaUnited States
-
Joseph J. CullenNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden... and other collaboratorsActive, not recruitingAdenocarcinoma | Pancreatic Neoplasms | Pancreas Cancer | Pancreas Neoplasms | Cancer of Pancreas | Cancer of the Pancreas | Neoplasms, PancreaticUnited States
-
National Cancer Institute (NCI)CompletedRefractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2United States
-
Baptist Health South FloridaAstraZenecaTerminatedAdenocarcinoma of the PancreasUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer | Resectable Pancreatic Carcinoma | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
Affiliated Hospital of Guangdong Medical UniversityEnrolling by invitationBile Duct Cancer | Pancreas Cancer | Ampullary Cancer | Duodenum CancerChina
-
University of NebraskaNational Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Stage III Pancreatic CancerUnited States
-
Spanish Cooperative Group for the Treatment of...CompletedMetastatic Pancreatic AdenocarcinomaSpain
-
BioNTech SETerminatedGastric Cancer | Pancreatic Cancer | Solid Tumor | Metastatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Canada
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
University of NebraskaNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Fate TherapeuticsTerminatedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumor | Small-cell Lung Cancer | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Bold Therapeutics, Inc.Active, not recruitingColorectal Cancer | Pancreatic Cancer | Cholangiocarcinoma | Gastric CancersKorea, Republic of, United States, Canada
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedMetastatic Adenocarcinoma of the Pancreas | Germline BRCA1/2 Mutations andUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Germany, Korea, Republic of, Australia, Israel, Netherlands
-
Gangnam Severance HospitalCompletedResectable Pancreatic AdenocarcinomaKorea, Republic of
-
University of NebraskaNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstituteOregon Health and Science University; Celgene CorporationCompletedPancreatic Adenocarcinoma | Resectable Pancreatic CarcinomaUnited States
-
University of ChicagoSuspended
-
The Christie NHS Foundation TrustPancreatic Cancer UKCompletedPancreas Adenocarcinoma | Pancreatic Neoplasm | Malignant Neoplasm of Pancreas | Well-Differentiated Neuroendocrine CarcinomaUnited Kingdom
-
Candel Therapeutics, Inc.CompletedPancreatic Cancer | Pancreatic AdenocarcinomaUnited States
-
University of FloridaCompletedPancreatic CancerUnited States
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
City of Hope Medical CenterActive, not recruitingLung Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma | Caregiver | Malignant Digestive System Neoplasm | Adult Liver CarcinomaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Comprehensive Cancer Centre The Netherlands; Dutch Cancer SocietyCompletedCarcinoma, Pancreatic DuctalNetherlands
-
HonorHealth Research InstituteBristol-Myers Squibb; Lustgarten Foundation; Translational Genomics Research...Active, not recruitingUntreated Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Medical College of WisconsinUniversity of CincinnatiCompletedPancreatic AdenocarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Vasgene Therapeutics, IncTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Pancreatic Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage... and other conditionsUnited States
-
McGill University Health Centre/Research Institute...Completed
-
Elevation OncologyActive, not recruitingSarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bladder Cancer | Metastatic Solid Tumor | Gallbladder Cancer | Uterine Cancer | Locally Advanced Solid TumorUnited States, Korea, Republic of, Australia, Canada
-
Hoffmann-La RocheTerminatedDigestive System Diseases | Gastrointestinal Diseases | Melanoma | Sarcoma | Neoplasms | Respiratory Tract Diseases | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasms | Head and Neck Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms and other conditionsUnited States
-
NCIC Clinical Trials GroupAstraZenecaCompleted
-
Klus Pharma Inc.CompletedCervical Cancer | Head and Neck Cancer | Mucoepidermoid Carcinoma | Pancreatic Cancer | Recurrent Prostate Cancer | Lung Cancer | Rectal Cancer | Solid Tumor | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Recurrent Ovarian Carcinoma | Bladder Cancer | Skin Cancer | HER2-positive Breast Cancer | Rare Diseases | Colo-rectal Cancer and other conditionsUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnMetastatic Pancreatic AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedEpithelioid Mesothelioma | Cholangiocarcinoma, Extrahepatic | Neoplasms With Mesothelin Expression | Adenocarcinoma, PancreaticUnited States
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Dynavax Technologies CorporationCompletedStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Refractory Pancreatic AdenocarcinomaUnited States
-
University of VirginiaActive, not recruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic AdenocarcinomaUnited States
-
Fondazione Policlinico Universitario Campus Bio-MedicoCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
Institute of Cancer Research, United KingdomVerastem, Inc.Active, not recruitingPancreatic Cancer | NSCLC | Low Grade Serous Ovarian Cancer | Endometrioid CarcinomaUnited Kingdom